TipRanks
Daito Pharmaceutical Co., Ltd. (JP:4577)
:4577
Japanese Market
4577
Daito Pharmaceutical Co., Ltd.
RESEARCH TOOLSreports
Want to see JP:4577 full AI Analyst Report?

Daito Pharmaceutical Co., Ltd. (4577) Income Statement

0 Followers

Daito Pharmaceutical Co., Ltd. Income Statement

Last quarter (Q4 2025), Daito Pharmaceutical Co., Ltd.'s total revenue was ¥13.92B, a decrease of -0.83% from the same quarter last year. In Q4, Daito Pharmaceutical Co., Ltd.'s net income was ¥893.00M. See Daito Pharmaceutical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
May 25May 24May 23May 22May 21
Total Revenue
¥ 50.65B¥ 50.64B¥ 46.90B¥ 45.10B¥ 43.46B
Gross Profit
¥ 9.90B¥ 8.47B¥ 9.67B¥ 10.15B¥ 11.31B
Operating Expenses
¥ 6.26B¥ 5.85B¥ 5.78B¥ 4.94B¥ 4.74B
Depreciation and Amortization
¥ 4.39B¥ 4.33B¥ 3.66B¥ 3.87B¥ 3.31B
EBITDA
¥ 8.02B¥ 7.41B¥ 7.92B¥ 8.96B¥ 10.04B
Operating Income
¥ 3.64B¥ 2.62B¥ 3.89B¥ 5.21B¥ 6.57B
Other Income/Expenses
¥ 428.00M¥ 337.00M¥ 324.00M¥ -136.00M¥ 152.00M
Pretax Income
¥ 4.07B¥ 2.96B¥ 4.22B¥ 5.08B¥ 6.72B
Net Income
¥ 3.16B¥ 1.91B¥ 3.29B¥ 3.60B¥ 4.67B
Per Share Metrics
Basic EPS
¥ 107.46¥ 62.72¥ 105.00¥ 113.82¥ 152.45
Diluted EPS
¥ 107.46¥ 62.72¥ 105.00¥ 113.72¥ 152.45
Weighted Average Shares Outstanding
 29.41M 30.42M 31.38M 31.63M 30.62M
Weighted Average Shares Outstanding (Diluted)
 29.41M 30.42M 31.38M 31.66M 30.62M
Currency in JPY

Daito Pharmaceutical Co., Ltd. Earnings and Revenue History